Hillman Capital Management
Superinvestor profile · Rank #147 by reported 13F value (2026 Q2 filers) · CIK 0001314620 · All profiles
Founded 1998Bethesda, Maryland, U.S.Value, quality businesses with a sustainable competitive advantage bought below intrinsic valueKey person: Mark A. Hillman (founder, principal owner, CEO and chief investment officer)
Reported 13F value
$138M
Period 2026-06-30 · Filed 2026-08-14
Positions
54
Top 10 = 36.3% of value
Clone CAGR (full window)
+9.9%
2020-02-14 → 2026-10-02 · cumulative +87%
SPY CAGR (same window)
+14.9%
Cumulative +151%
Max drawdown (monthly)
-25%
Month-end values, approximate
Latest-quarter activity
3 new · 5 exited
14 increased · 35 decreased
Hypothetical clone — not this fund's returns. The performance on this page replicates only the long U.S. equity positions disclosed on this manager's Form 13F filings, rebalanced on filing dates at disclosed weights with dividend-adjusted prices. It excludes shorts, bonds, cash, non-U.S. listings, private holdings, leverage and fees. Treat it as a measure of how the disclosed stock picks performed, never as the fund's track record. Evidence: filing-by-filing dossier (PDF) · Methodology (PDF)
Clone performance
| Window | Clone CAGR | Note |
|---|---|---|
| Full window (2020-02-14 → 2026-10-02, 27 filings) | +9.87% | Cumulative +86.6% vs SPY +150.7% |
| Trailing 10Y | — | |
| Trailing 5Y | +7.96% | |
| Trailing 3Y | +11.85% | |
| Trailing 1Y | +11.37% |
Top holdings — 2026 Q2 filing
| Ticker | Company | Weight | Reported value |
|---|---|---|---|
| CVS | Cvs Health Corp | 4.15% | $6M |
| BIIB | Biogen Inc | 3.75% | $5M |
| DD | Dupont De Nemours Inc | 3.71% | $5M |
| WBD | Warner Bros Discovery Inc | 3.67% | $5M |
| BAX | Baxter Intl Inc | 3.64% | $5M |
| IFF | International Flavors&Fragra | 3.61% | $5M |
| GSK | Gsk Plc | 3.51% | $5M |
| KMX | Carmax Inc | 3.50% | $5M |
| BA | Boeing Co | 3.38% | $5M |
| ZBH | Zimmer Biomet Holdings Inc | 3.36% | $5M |
As reported on the 2026-06-30 Form 13F (filed 2026-08-14). Full holdings and quarter changes: holdings page.
Filing history in this profile
Every clone input traces to one of these SEC filings. 99.2% of the latest filing's reported value is covered by our price history; the remainder is mostly non-U.S. listings, recent IPOs or delisted names and is excluded from the clone.
Background (founded / HQ / style) source: https://hillmanfunds.com/assets/pdfs/adv.pdf — Form ADV brochure: Hillman Capital Management, Inc. was established in 1998 and founded by Mark A. Hillman, bringing in assets of predecessor firms he established in the early 1990s; HCM first located in Annapolis, Maryland and moved to Bethesda, Maryland in April 2005, and the Hillman Value Fund was formed in 2000.